PREDICTIVE ONCOLOGY POAI 深 沪
已收盘 12-11 16:00:00 美东时间
5.95
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 5.95
- 总市值 2505.78万
- 52周最高 45.90
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.88
- 委 比 0.00%
- 总股本 421.14万
- 历史最高 2550.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.25
- 每 手 1
- 风险率 3.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Axe Compute outlines $7.7M in contracted 2026 income following $12M in signed contract value
Earnings Call Insights: Axe Compute Inc. (AGPU) Q4 2025 Management View CEO Christopher Miglino framed the company’s recent pivot around a GPU capacity platform and AI infrastructure, saying, "In Sept...
04-01 22:52
Axe Compute appoints Christopher Miglino as CEO
Axe Compute (AGPU) announced on Monday the appointment of Christopher Miglino as chief executive officer. The company said that Miglino's transitions into the CEO role followed his involvement in the ...
02-09 22:26
Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute
Axe Compute appoints Christopher Miglino as CEO to advance its decentralized compute and digital infrastructure. Miglino will lead the company's strategy to develop institutional-grade AI infrastructure, expand its compute platform, and strengthen its treasury and operational capabilities. The company, operating at the intersection of blockchain, AI, and capital markets, aims to enable a decentralized future while providing accessible, enterprise...
02-09 13:00
Predictive Oncology Amends Bylaws to Reflect Name Change to Axe Compute
Predictive Oncology Inc. has amended its bylaws in connection with a corporate name change to Axe Compute Inc., effective December 11, 2025. The amendments update the bylaws to reflect the new name an...
2025-12-11 19:00
Predictive Oncology Regains Nasdaq Compliance
Predictive Oncology ( ($POAI) ) has provided an update. On December 1, 2025, Pr...
2025-12-03 06:54
Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
Predictive Oncology Inc. (NASDAQ: POAI) announced it regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million, allowing its shares to continue trading on the Nasdaq Capital Market under "POAI." The company highlighted its progress in strengthening its financial position and preserving investor confidence while expanding its digital asset strategy focused on the Aethir (ATH) token. Predictive Oncology uses AI and ...
2025-12-02 13:00
Predictive Oncology Regains Nasdaq Compliance with Investments
Predictive Oncology ( ($POAI) ) just unveiled an update. Predictive Oncology In...
2025-11-21 06:50
Predictive Oncology Unveils New Digital Asset Strategy
An update from Predictive Oncology ( ($POAI) ) is now available. On November 17...
2025-11-17 21:26
Predictive Oncology Updates ATM Offering Program
The latest announcement is out from Predictive Oncology ( ($POAI) ). On October...
2025-10-30 05:54
Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy
Predictive Oncology Inc. has expanded its leadership team and Board of Directors to support its new digital asset treasury strategy centered on the Aethir (ATH) token. Shawn Matthews, CEO of DNA Holdings Venture, Inc. and former CEO of Cantor Fitzgerald, has joined the Board. Thomas McLaughlin, CIO of DNA Holdings, is now the Chief Investment Officer, and Sara Turken, a biopharmaceutical veteran, has been appointed as General Counsel. The company...
2025-10-14 12:00
